default author photo

Rajeev Vadakkedath

PPD India Pvt Ltd

Mumbai

India

SCHOLARLY PAPERS

1

DOWNLOADS

377

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

A Phase 2/3, Observer-Blind, Randomised, Controlled Study to Assess the Safety and Immunogenicity of SII-ChAdOx1 nCOV-19 (COVID-19 Vaccine) in Adults in India

Number of pages: 32 Posted: 09 Aug 2021
Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR) - National Institute for Research in Tuberculosis, AstraZeneca Biopharmaceuticals, KEM Hospital Research Centre - Vadu Budruk, Post Graduate Institute of Medical Education & Research (PGIMER), JSS Academy of Higher Education and Research, Mahatma Gandhi Institute of Medical Sciences, Seth G S Medical College & KEM Hospital, B J Government Medical College and Sassoon General Hospitals, Bharati Vidyapeeth (Deemed to be University) - Department of Pediatrics, Jehangir Clinical Development Centre, Topiwala National Medical College & B. Y. L. Nair Hospital, Government Medical College, Directorate of Public Health and Preventive Medicine, Indian Council of Medical Research (ICMR) - Rajendra Memorial Research Institute of Medical Sciences, Andhra Medical College, Sri Ramchandra Institute of Higher Education and Research, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, PPD India Pvt Ltd, PPD Laboratories Inc, - Vaccine Sciences Department, Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), AstraZeneca Pharmaceuticals - AstraZeneca R&D, Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd and Independent
Downloads 377 (195,842)
Citation 1

Abstract:

Loading...